Research progress of PLGA nanoparticle as non-viral gene delivery system

Wei-Wei ZOU,Na ZHANG

2009-01-01

Abstract:Biodegradable PLGA nanoparticle is a promising nonviral gene delivery systems.In the present review,several respects such as the advantages,the factors affecting cellular internalization and transfection efficiency as well as the limita-tions and measures of this gene delivery system have been summarized.

What problem does this paper attempt to address?

Advance in the Study of Poly(lactide-Co-glycolide) Nano/microparticles As Gene Vector

Ping Zeng,Ming-Li Peng,Yi Xu

DOI: https://doi.org/10.16438/j.0513-4870.2010.11.001

2010-01-01

Abstract:Biodegradable nano/microparticles of poly(D, L-lactide-co-glycolide) (PLGA) is a novel non-viral gene vector, which has many advantages, such as safety, non-immunogenicity, easy of large-scale preparation and well load-capability. Therefore, more and more attentions and researches have been paid on its application. Especially, PLGA has shown enormous potential application value and space in the field of plasmid DNA (pDNA) delivery system. On the basis of the current situation of PLGA nano/microparticles for pDNA delivery, this paper focused on summarizing the current preparation approaches and surface modified methods of PLGA particle, furthermore showing its application in gene therapy and genetic vaccine delivery. These showed that PLGA nano/microparticles have extensive prospect in the development of controlled gene delivery system.
Progress in Non-Viral Gene Delivery Systems Fabricated Via Supramolecular Assembly

Youxiang Wang,Jiacong Shen

DOI: https://doi.org/10.1007/bf02897567

2005-01-01

Chinese Science Bulletin

Abstract:Gene delivery systems are one of key issues that limit the development of gene therapy. The novel non-viral gene delivery systems fabricated via supramolecular assembly have begun to show increasing promising and applications in gene therapy due to its suitable nanometric size, controllable structure and excellent biocompatibility. In this review, the fundamental and recent progress of non-viral gene supramolecular assembly is reviewed. Artificial viruses the future direction of non-viral gene delivery systems are also described.
Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA

Weiwei Zou,Chunxi Liu,Zhijin Chen,Na Zhang

DOI: https://doi.org/10.1007/s11671-009-9345-3

2009-01-01

Nanoscale Research Letters

Abstract:The purpose of the present work was to formulate and evaluate cationic poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) nanoparticles as novel non-viral gene delivery nano-device. Cationic PLA-PEG nanoparticles were prepared by nanoprecipitation method. The gene loaded nanoparticles were obtained by incubating the report gene pEGFP with cationic PLA-PEG nanoparticles. The physicochemical properties (e.g., morphology, particle size, surface charge, DNA binding efficiency) and biological properties (e.g., integrity of the released DNA, protection from nuclease degradation, plasma stability, in vitro cytotoxicity, and in vitro transfection ability in Hela cells) of the gene loaded PLA-PEG nanoparticles were evaluated, respectively. The obtained cationic PLA-PEG nanoparticles and gene loaded nanoparticles were both spherical in shape with average particle size of 89.7 and 128.9 nm, polydispersity index of 0.185 and 0.161, zeta potentials of +28.9 and +16.8 mV, respectively. The obtained cationic PLA-PEG nanoparticles with high binding efficiency (>95%) could protect the loaded DNA from the degradation by nuclease and plasma. The nanoparticles displayed sustained-release properties in vitro and the released DNA maintained its structural and functional integrity. It also showed lower cytotoxicity than Lipofectamine 2000 and could successfully transfect gene into Hela cells even in presence of serum. It could be concluded that the established gene loaded cationic PLA-PEG nanoparticles with excellent properties were promising non-viral nano-device, which had potential to make cancer gene therapy achievable.
Biodegradable tri-block copolymer poly(lactic acid)-poly(ethylene glycol)-poly(l-lysine)(PLA-PEG-PLL) as a non-viral vector to enhance gene transfection

Chunhua Fu,Xiaoli Sun,Donghua Liu,Zhijing Chen,Zaijun Lu,Na Zhang

DOI: https://doi.org/10.3390/ijms12021371

2011-02-23

Abstract:Low cytotoxicity and high gene transfection efficiency are critical issues in designing current non-viral gene delivery vectors. The purpose of the present work was to synthesize the novel biodegradable poly (lactic acid)-poly(ethylene glycol)-poly(l-lysine) (PLA-PEG-PLL) copolymer, and explore its applicability and feasibility as a non-viral vector for gene transport. PLA-PEG-PLL was obtained by the ring-opening polymerization of Lys(Z)-NCA onto amine-terminated NH(2)-PEG-PLA, then acidolysis to remove benzyloxycarbonyl. The tri-block copolymer PLA-PEG-PLL combined the characters of cationic polymer PLL, PLA and PEG: the self-assembled nanoparticles (NPs) possessed a PEG loop structure to increase the stability, hydrophobic PLA segments as the core, and the primary ɛ-amine groups of lysine in PLL to electrostatically interact with negatively charged phosphate groups of DNA to deposit with the PLA core. The physicochemical properties (morphology, particle size and surface charge) and the biological properties (protection from nuclease degradation, plasma stability, in vitro cytotoxicity, and in vitro transfection ability in HeLa and HepG2 cells) of the gene-loaded PLA-PEG-PLL nanoparticles (PLA-PEG-PLL NPs) were evaluated, respectively. Agarose gel electrophoresis assay confirmed that the PLA-PEG-PLL NPs could condense DNA thoroughly and protect DNA from nuclease degradation. Initial experiments showed that PLA-PEG-PLL NPs/DNA complexes exhibited almost no toxicity and higher gene expression (up to 21.64% in HepG2 cells and 31.63% in HeLa cells) than PEI/DNA complexes (14.01% and 24.22%). These results revealed that the biodegradable tri-block copolymer PLA-PEG-PLL might be a very attractive candidate as a non-viral vector and might alleviate the drawbacks of the conventional cationic vectors/DNA complexes for gene delivery in vivo.
Nanoparticles for Gene Delivery: A Brief Patent Review

Guoxiao Xu,Na Zhang

DOI: https://doi.org/10.2174/187221109788452258

2009-01-01

Recent Patents on Drug Delivery & Formulation

Abstract:Gene therapy, as therapeutic treatment to genetic or acquired diseases, is attracting much interest in the research community, leading to noteworthy developments over the past two decades. Nonviral vectors have recently received an increasing attention in order to overcome the safety problems of viral counterpart. Nanoparticles with their special characteristics such as small particle size, large surface area and the capability of changing their surface properties have numerous advantages compared with other gene delivery systems. This article reviews the advances of nanoparticles in patents for gene delivery and emphasizes methods to promote gene transfection efficiency.
Recent Applications of PLGA in Drug Delivery Systems

Jie Yang,Huiying Zeng,Yusheng Luo,Ying Chen,Miao Wang,Chuanbin Wu,Ping Hu

DOI: https://doi.org/10.3390/polym16182606

IF: 5

2024-09-15

Polymers

Abstract:Poly(lactic-co-glycolic acid) (PLGA) is a widely used biodegradable and biocompatible copolymer in drug delivery systems (DDSs). In this article, we highlight the critical physicochemical properties of PLGA, including its molecular weight, intrinsic viscosity, monomer ratio, blockiness, and end caps, that significantly influence drug release profiles and degradation times. This review also covers the extensive literature on the application of PLGA in delivering small-molecule drugs, proteins, peptides, antibiotics, and antiviral drugs. Furthermore, we discuss the role of PLGA-based DDSs in the treating various diseases, including cancer, neurological disorders, pain, and inflammation. The incorporation of drugs into PLGA nanoparticles and microspheres has been shown to enhance their therapeutic efficacy, reduce toxicity, and improve patient compliance. Overall, PLGA-based DDSs holds great promise for the advancement of the treatment and management of multiple chronic conditions.

polymer science
Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancer.

Weiwei Zou,Chunxi Liu,Zhijin Chen,Na Zhang

DOI: https://doi.org/10.1016/j.ijpharm.2008.11.016

IF: 6.51

2009-01-01

International Journal of Pharmaceutics

Abstract:The study aimed to design novel bioadhesive PLGA nanoparticles for efficient gene delivery to lung cancer cells. The bioadhesive agent and stabilizer, Carbopol 940 was chosen to establish bioadhesive PLGA nanoparticles and Pluronic F68, Pluronic F127 stabilized PLGA nanoparticles were formulated as control. The effects of different surfactants on the physicochemical and biological characterizations of PLGA nanoparticles were compared. All the obtained nanoparticles showed negative surface charge, similar spherical morphology, a relatively narrow particle size distribution, and lower cytotoxicity to A549 cells comparing with Lipofectamine 2000. Carbopol stabilized nanoparticles hold advantages in DNA-binding efficiency (>80%) at an optimal Carbopol concentration, DNA protection from enzymatic degradation in vitro release and better buffering capacity. Most importantly, higher transfection efficiency in A549 cells was observed comparing to Pluronics stabilized nanoparticles or naked DNA, similar to that of Lipofectamine 2000. These results revealed that the bioadhesive PLGA nanoparticles formulated with Carbopol might be a very attractive candidate as a non-viral vector for lung cancer gene therapy and might alleviate the drawbacks of the conventional cationic vectors/DNA complexes for gene delivery in vivo.
Novel cationic 6-lauroxyhexyl lysinate modified poly(lactic acid)-poly(ethylene glycol) nanoparticles enhance gene transfection.

Chunxi Liu,Zhijin Chen,Wangyang Yu,Na Zhang

DOI: https://doi.org/10.1016/j.jcis.2010.10.062

IF: 9.9

2011-01-01

Journal of Colloid and Interface Science

Abstract:The leading principle of non-viral delivery systems for gene therapy is to mediate high levels of gene expression with low cytotoxicity. Nowadays, biodegradable nanoparticles formulated with poly(lactic acid)–poly(ethylene glycol) (PLA–PEG) were wildly developed. However, the relative lower gene transfection efficiency and higher cytotoxicity still remained critical problems. To address these limitations, PLA–PEG nanoparticles have been composited with other components in their formulation. Here, a novel cationic lipid, 6-lauroxyhexyl lysinate (LHLN), was fabricated onto PLA–PEG nanoparticles as a charge modifier to improve the transfection efficiency and cytotoxicity. The obtained cationic LHLN modified PLA–PEG nanoparticles (LHLN–PLA–PEG NPs) could condense pDNA thoroughly via electrostatic force, leading to the formation of the LHLN–PLA–PEG NPs/pDNA complexes (NPs/DNA complexes). The nanoparticles obtained have been characterized in relation to their physicochemical and biological properties, and the results are extremely promising in terms of low cell toxicity and high transfection efficiency. These results indicated that the novel cationic LHLN modified PLA–PEG nanoparticles could enhance gene transfection in vitro and hold the potential to be a promising non-viral nanodevice.
A Mini Review of Biodegradable Calcium Phosphate Nanoparticles for Gene Delivery.

Ying Xie,Yun Chen,Minjie Sun,Qineng Ping

DOI: https://doi.org/10.2174/1389201014666131226145441

2014-01-01

Current Pharmaceutical Biotechnology

Abstract:Nucleic acid drugs are promising new therapeutics for the treatment of various diseases including genetic diseases, viral diseases, and cancer. However, their poor intracellular bioavailability and rapid degradation hinder their development as drugs. Therefore, the main challenge is to develop an efficient delivery system. Calcium phosphate has been widely used to transfect cultured cells for 40 years, due to its safety, simply of production and noticeable efficacy of transfection. Unfortunately, calcium phosphate particles show poor colloidal stability because of uncontrolled growth, which impedes their practical use. Recently, investigators have designed a variety of biodegradable calcium phosphate nanocarriers and achieved efficient gene delivery both in vitro and in vivo with low toxicity. In this review, we focus on the current research activity in the development of calcium phosphate nanoparticlss for gene delivery. Calcium phosphate nanoparticles are mainly classified into lipid coated and polymer coated ones for discussion. In addition, cellular uptake and intracellular trafficking of calcium phosphate nanoparticles are also mentioned.
Current advances in research and clinical applications of PLGA-based nanotechnology.

Jian-Ming Lü,Xinwen Wang,Christian Marin-Muller,Hao Wang,Peter H Lin,Qizhi Yao,Changyi Chen

DOI: https://doi.org/10.1586/ERM.09.15

2014-01-01

Expert Review of Molecular Diagnostics

Abstract:Co-polymer poly(lactic-co-glycolic acid) (PLGA) nanotechnology has been developed for many years and has been approved by the US FDA for the use of drug delivery, diagnostics and other applications of clinical and basic science research, including cardiovascular disease, cancer, vaccine and tissue engineering. This article presents the more recent successes of applying PLGA-based nanotechnologies and tools in these medicine-related applications. It focuses on the possible mechanisms, diagnosis and treatment effects of PLGA preparations and devices. This updated information will benefit to both new and established research scientists and clinical physicians who are interested in the development and application of PLGA nanotechnology as new therapeutic and diagnostic strategies for many diseases.
Current Advances in Research and Clinical Applications of PLGA-based Nanotechnology

Jianming Lü,Xinwen Wang,Christian Marín‐Müller,Hao Wang,Peter H. Lin,Qizhi Yao,Changyi Chen

DOI: https://doi.org/10.1586/erm.09.15

2009-01-01

Expert Review of Molecular Diagnostics

Abstract:Co-polymer poly(lactic-co-glycolic acid) (PLGA) nanotechnology has been developed for many years and has been approved by the US FDA for the use of drug delivery, diagnostics and other applications of clinical and basic science research, including cardiovascular disease, cancer, vaccine and tissue engineering. This article presents the more recent successes of applying PLGA-based nanotechnologies and tools in these medicine-related applications. It focuses on the possible mechanisms, diagnosis and treatment effects of PLGA preparations and devices. This updated information will benefit to both new and established research scientists and clinical physicians who are interested in the development and application of PLGA nanotechnology as new therapeutic and diagnostic strategies for many diseases.
Polymeric Nanocarriers for Non-Viral Gene Delivery

changyang gong,yuquan wei,ling li

DOI: https://doi.org/10.1166/jbn.2015.2069

2015-01-01

Journal of Biomedical Nanotechnology

Abstract:Gene therapy holds great promise for the treatment of acquired and inherited diseases. Non-viral gene delivery systems are gaining recognition as alternatives to viral gene vectors due to their safety and low immunogenicity. The effective delivery of nucleic acids requires overcoming many biological barriers that would otherwise hinder transfection efficiency. Developing safe and efficient vectors that can overcome these obstacles is at the heart of current gene delivery research. Polymeric nanocarriers, such as polyethylenimine (PEI), poly(L-lysine) (PLL), poly[2-(dimethylamino) ethyl methacrylate] (PDMAEMA), polyamidoamine (PAMAM), chitosan and poly(amino-co-ester)s (PAEs), play an important role in gene delivery. In this review, we first describe the current understanding of the biological barriers to non-viral gene delivery and recent progress in addressing these barriers. Several of the most widely used non-viral polymeric nanocarriers are discussed, and detailed strategies that have accumulated from nearly two decades of research aimed at overcoming biological barriers and improving gene transfer are highlighted.
Progress of inorganic nanoparticles as gene delivery vectors

LI Xin-xin,HOU Sen,FENG Xi-zeng

DOI: https://doi.org/10.3969/j.issn.1004-0374.2008.03.018

2008-01-01

Abstract:Transfection is defined as the delivery of functional nucleic acids into living cells,maintaining the biological function of the nucleic acids.As an important technique in biochemistry and molecular biology, transfection is meaningful for its potential applications in gene therapy.Inorganic nanoparticles can be used as gene delivery vectors and have received extensive interest due to their various advantages,such as easy preparation and surface-functionalization.This paper reviewed the current researches about inorganic nanoparticles as gene delivery vectors.Their influence on the gene expression was also discussed.
Research progress of layer-by-layer-assembled nanoparticles as non-viral gene delivery system

LIU Chunxi,ZHANG Na

DOI: https://doi.org/10.13488/j.smhx.2011.04.016

2011-01-01

Abstract:The layer-by-layer(LbL) method for the deposition of oppositely charged polyelectrolytes on solid substrates has been well-established as a convenient approach to the bottom-up assembly of multilayered polymer films.The ease of preparation,stability of multilayers formed,nanoscale controllability of film thickness,applicability to various charged species make it be an attractive technique for the production of biomimetic structures that can find applications in biomaterialogy,biology,and gene delivery.Here,the research progress of LBL nanoparticles as non-viral gene delivery system and our group in this direction is reviewed.
Study on the Preparation and Transfer Efficiency of New Nanoparticles Gene Delivery PAMAM-PLGA

LIU Jun-an,LI Hai-bing,Wang Wei,YANG Xiang-liang,XU Hui-bi

DOI: https://doi.org/10.3321/j.issn:1001-5213.2007.02.023

2007-01-01

Abstract:OBJECTIVE To preparation higher transfer efficiency gene delivery,we prepared PAMAM-PLGA new nanoparticles gene delivery and evaluated their transfer efficiency.METHODS PAMAM-PLGA nanoparticles were prepared by solvent evaporation method.By investigating nanoparticles size and distribution,nanoparticles morpHology,nanoparticles stability,pH and zeta potential,the relations between properties and synthetic process were studied and found out a set of desired process conditions.We used gel retardation assay experiment and green fluorescence protein marker to investigate their transfer efficiency.The result indicated that the new gene delivery can carry DNA into cells.RESULTS The result indicated that the new gene delivery can carry DNA into cells.CONCLUSION Higher transfer efficiency gene delivery PAMAM-PLGA nanoparticles were prepared by solvent evaporation method.The nanoparticles size was about 100nm and PDI was 0.088.The transfer efficiency of PAMAM-PLGA was higher than pure PAMAM.
Preparation, Characterization and Transfection Efficiency of Cationic PEGylated PLA Nanoparticles As Gene Delivery Systems.

Jiji Chen,Buning Tian,Xiang Yin,Yanqiong Zhang,Duosha Hu,Zhiyuan Hu,Meizhou Liu,Yifeng Pan,Jinfeng Zhao,Hao Li,Can Hou,Jiwei Wang,Yangde Zhang

DOI: https://doi.org/10.1016/j.jbiotec.2007.02.007

IF: 3.595

2007-01-01

Journal of Biotechnology

Abstract:The cationic polylactic acid (PLA) nanoparticle has emerged as a promising non-viral vector for gene delivery because of its biocompatibility and biodegradability. However, they are not capable of prolonging gene transfer and high transfection efficiency. In order to achieve prolonged delivery of cationic PLA/DNA complexes and higher transfection efficiency, in this study, we used copolymer methoxypolyethyleneglycol-PLA (MePEG-PLA), PLA and chitosan (CS) to prepare MePEG-PLA-CS NPs and PLA-CS NPs by a diafiltration method and prepared NPs/DNA complexes through the complex coacervation of nanoparticles with the pDNA. The object of our work is to evaluate the characterization and transfection efficiency of MePEG-PLA-CS versus PLA-CS NPs. The MePEG-PLA-CS NPs have a zeta potential of 15.7 mV at pH 7.4 and size under 100 nm, while the zeta potential of PLA-CS NPs was only 4.5 mV at pH 7.4. Electrophoretic analysis suggested that both MePEG-PLA-CS NPs and PLA-CS NPs with positive charges could protect the DNA from nuclease degradation and cell viability assay showed MePEG-PLA-CS NPs exhibit a low cytotoxicity to normal human liver cells. The potential of PLA-CS NPs and MePEG-PLA-CS NPs as a non-viral gene delivery vector to transfer exogenous gene in vitro and in vivo were examined. The pDNA being carried by MePEG-PLA-CS NPs, PLA-CS NPs and lipofectamine could enter and express in COS7 cells. However, the transfection efficiency of MePEG-PLA-CS/DNA complexes was better than PLA-CS/DNA and lipofectamine/DNA complexes by inversion fluorescence microscope and flow cytometry. It was distinctively to find that the transfection activity of PEGylation of complexes was improved. The nanoparticles were also tested for their ability to transport across the gastrointestinal mucosa in vivo in mice. In vivo experiments showed obviously that MePEG-PLA-CS/DNA complexes mediated higher gene expression in stomach and intestine of BALB/C mice compared to PLA-CS/DNA and lipofectamine/DNA complexes. These results suggested that MePEG-PLA-CS NPs have favorable properties for non-viral gene delivery.
Recent Advances in the Non-Viral Gene Delivery System

QIN Zhi-qiang,LUO Sai-qun,HU Wei-xin

DOI: https://doi.org/10.3969/j.issn.1673-2588.2007.02.012

2007-01-01

Abstract:Although viral vector systems are efficient to transfect genes into a variety of tissues,safety issues remain in relation to human gene therapy.This review describes the basic principles behind various physical and chemical methods for gene transfer and assesses the advantages and performance of such approaches,compared to other transfection systems.In particular,the efficiency of gene delivery,the toxicity,in vivo feasibility,and targeting ability of different non-viral methodologies are discussed and evaluated.
DOTAP-Incorporated PEG-PLGA Nanoparticles for Efficient in Vitro and in Vivo Gene Delivery.

Min Yu,Ke Wang,Han Zhang,Qian Liu,Jin Wang,Li Cao,Wenjing Li,Kai Wang,Zhangyong Hong

DOI: https://doi.org/10.1166/jbn.2018.2470

2018-01-01

Journal of Biomedical Nanotechnology

Abstract:The application of nucleic acids as therapeutic agents has been obstructed by the lack of efficient and safe systems for the delivery of the therapeutic DNA into target cells. Nanoparticle (NP) vectors based on biocompatible and biodegradable poly(D,L-lactic-co-glycolic acid) (PLGA) polymers, especially the PEGylated ones, seem to be promising drug delivery systems but are far from being ideal gene delivery systems. Given the broad potential of PEGylated PLGA (PEG-PLGA) NPs in the biomedical applications, here, we designed and optimized a PEG-PLGA NP system by incorporating cationic lipids as the excipients for improving the gene delivery efficiency. Systemic investigation of this system by varying the type of the cationic lipids and PEG-PLGA polymers, preparation conditions, transfection conditions and cell lines was carried out, with the aim of finding a relatively efficient formulation for in vivo gene delivery. The optimized NP system showed excellent pDNA transfection efficacy both in vitro and in vivo, while much lower cytotoxicity than commercial Lipofectamine™ 2000 (Lip2000). The prepared system may be very useful for in vivo delivery of gene therapies to targeted cells.
Application of Non-Viral Vectors in Drug Delivery and Gene Therapy

Shuaikai Ren,Mengjie Wang,Chunxin Wang,Yan Wang,Changjiao Sun,Zhanghua Zeng,Haixin Cui,Xiang Zhao

DOI: https://doi.org/10.3390/polym13193307

IF: 5

2021-09-28

Polymers

Abstract:Vectors and carriers play an indispensable role in gene therapy and drug delivery. Non-viral vectors are widely developed and applied in clinical practice due to their low immunogenicity, good biocompatibility, easy synthesis and modification, and low cost of production. This review summarized a variety of non-viral vectors and carriers including polymers, liposomes, gold nanoparticles, mesoporous silica nanoparticles and carbon nanotubes from the aspects of physicochemical characteristics, synthesis methods, functional modifications, and research applications. Notably, non-viral vectors can enhance the absorption of cargos, prolong the circulation time, improve therapeutic effects, and provide targeted delivery. Additional studies focused on recent innovation of novel synthesis techniques for vector materials. We also elaborated on the problems and future research directions in the development of non-viral vectors, which provided a theoretical basis for their broad applications.

polymer science
Advance in the Study of Chitosan and its Derivatives as Non-Viral Vectors

HUANG Jin,WANG Shi-long,SUN Xiao-yu,LI Wen-zhe,YAO Si-de

DOI: https://doi.org/10.3969/j.issn.1003-3726.2006.01.010

2006-01-01

Abstract:Recently chitosan is focused in the research of gene delivery system for it is already known as a biocompatible,biodegradable and non-toxic polysaccharide.This article is to summarize the recent development of chitosan and its derivatives as non-viral vectors for gene transfection.And the influential factors of the transfection efficiency are also discussed such as molecular mass of chitosan,size of chitosan nanoparticle and depolymerization of chitosan.

Research progress of PLGA nanoparticle as non-viral gene delivery system

Advance in the Study of Poly(lactide-Co-glycolide) Nano/microparticles As Gene Vector

Progress in Non-Viral Gene Delivery Systems Fabricated Via Supramolecular Assembly

Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA

Biodegradable tri-block copolymer poly(lactic acid)-poly(ethylene glycol)-poly(l-lysine)(PLA-PEG-PLL) as a non-viral vector to enhance gene transfection

Nanoparticles for Gene Delivery: A Brief Patent Review

Recent Applications of PLGA in Drug Delivery Systems

Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancer.

Novel cationic 6-lauroxyhexyl lysinate modified poly(lactic acid)-poly(ethylene glycol) nanoparticles enhance gene transfection.

A Mini Review of Biodegradable Calcium Phosphate Nanoparticles for Gene Delivery.

Current advances in research and clinical applications of PLGA-based nanotechnology.

Current Advances in Research and Clinical Applications of PLGA-based Nanotechnology

Polymeric Nanocarriers for Non-Viral Gene Delivery

Progress of inorganic nanoparticles as gene delivery vectors

Research progress of layer-by-layer-assembled nanoparticles as non-viral gene delivery system

Study on the Preparation and Transfer Efficiency of New Nanoparticles Gene Delivery PAMAM-PLGA

Preparation, Characterization and Transfection Efficiency of Cationic PEGylated PLA Nanoparticles As Gene Delivery Systems.

Recent Advances in the Non-Viral Gene Delivery System

DOTAP-Incorporated PEG-PLGA Nanoparticles for Efficient in Vitro and in Vivo Gene Delivery.

Application of Non-Viral Vectors in Drug Delivery and Gene Therapy

Advance in the Study of Chitosan and its Derivatives as Non-Viral Vectors